EuBiologics

EuBiologics Co., Ltd. is a biopharmaceutical company based in Seoul, South Korea, focused on developing and supplying vaccines to address epidemics and antibiotic resistance. The company offers innovative products such as Euvchol, an oral cholera vaccine, and CRM197, a diphtheria toxin mutant vaccine. In addition to its vaccine development, EuBiologics provides customized services for the production of biopharmaceuticals derived from mammalian and microbial cells. These services encompass cell line development, GMP production, validation, and regulatory support. The company also specializes in the manufacture of recombinant biological products and antibody therapeutics. Furthermore, EuBiologics offers process development, formulation, analytical method development, and contract testing services, including lot release and stability testing. Founded in 2010, EuBiologics is dedicated to advancing healthcare solutions through its comprehensive biopharmaceutical capabilities.